DOV Pharmaceutical CEO Leslie Hudson has resigned in a management shakeup. CFO Barbara Duncan has added the president's title to her portfolio and Chief Scientific Officer Phil Skolnick was given extra duties.
OXiGENE has named Richard Chin as president and CEO. Chin has worked at Elan as senior vice president and head of global development.
Orchid Cellmark announced that Raymond J. Land, senior vice president and CFO, has resigned from the company to pursue other interests.
Transport Pharmaceuticals has named Sean Moran CFO.
Don Evans has given notice to resign from his position as vice president corporate communications of Wex Pharmaceuticals.
Solexa has named Richard H. Lussier to the newly-created position of vice president, sales and field operations.
Jean-Luc Martre, Advitech's vice-president sales and marketing, has announced plans to leave the company. Christian Brouillette MSc, MBA, will become Advitech's new sales and marketing director.
IsoRay Medical has named Eric Knipfer Southeast Area director.
Dr. Sveinbjorn Gizurarson has joined Kurve Technology's Scientific Advisory Board.
Homer L. Pearce, Ph.D., and David C. Stump, M.D., have been appointed to Sunesis Pharmaceuticals' board of directors.
Amicus Therapeutics has named Glenn P. Sblendorio to its board of directors.
Jerini has appointed Zsolt Lavotha and Dr. Günter Stock to its supervisory board.